FLORHAM PARK, N.J., Oct. 30, 2019 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the […]
Revenue$102.5 million for 9M 2019$37.0 million for Q3 2019Cash from operating activities$24.3 million for 9M 2019$15.0 million for Q3 2019EBITDA$41.4 […]